Abstract
Human C-reactive protein (CRP) is a reactant involved in the acute phase response and one of the many molecular factors involved in pathogenesis of coronary artery disease (CAD). CRP gene variants potentially mediate CRP plasma concentrations and the development of CAD. 220 Croatian subjects with angiographically confirmed CAD and 132 control subjects were included in the study. CRP gene polymorphisms 1059G/C and -717G/A were determined by RFLPs, using MaeIII and KspI endonuclease, respectively. Plasma concentrations of CRP and homocysteine were determined by immunoturbidimetry and FPIA, respectively. CRP 1059G/C gene variants were significantly associated with CAD (OR = 0.50; 95% CI = 0.27, 0.94; P = 0.032). Wild GG genotype and rare allele C carrier genotypes were 184 and 22 in CAD(+) group, and 101 and 24 in CAD(−) group, respectively. Multivariate analysis with age, gender, BMI, smoking status, hypertension and diabetes as covariates showed that 1059C carriers had lower CRP concentrations in CAD(−) (P = 0.010) and CAD(+) subjects (P = 0.028). This allele was also significantly associated with lower plasma homocysteine concentrations in both groups (P = 0.018 for CAD(−) and 0.002 for CAD(+). There was no significant difference between CAD(+) and CAD(−) subjects in absolute frequencies for CRP -717A/G gene variant, but multivariate analysis showed that carriers of the rarer G allele had significantly higher CRP plasma concentrations in CAD(−) subjects (P = 0.031) and higher homocysteine concentrations in CAD(+) group (P < 0.001). Atherosclerosis is an inflammatory disease resulting from different genetic and environmental factors. Results presented here support the contribution of CRP genetic variations in the development of CAD.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CAD:
-
Coronary artery disease
- CRP:
-
C-reactive protein
- ICAM-1:
-
Intercellular adhesion molecule-1
- IL:
-
Interleukin
- HDL-C:
-
High density lipoprotein cholesterol
- LDL-C:
-
Low density lipoprotein cholesterol
- MI:
-
Myocardial infarction
- MCP-1:
-
Monocyte chemoattractant molecule-1
- NF-κB:
-
Nuclear factor kappaB
- TNF-α:
-
Tumor necrosis factor-α
- VCAM-1:
-
Vascular cell adhesion molecule-1
References
Kushner I (1982) The phenomena of acute phase response. Ann NY Acad Sci USA 389:39–48
de Ferranti S, Rifai N (2002) C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 317:1–15
Li JJ, Fang CH (2004) C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 62:499–506
Ballou SP, Kushner I (1992) C-reactive protein and the acute phase response. Adv Intern Med 37:313–336
Francisco G, Hernández C, Simó R (2006) Serum markers of vascular inflammation in dyslipemia. Clin Chim Acta 369:1–16
Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397
Ridker PM, Cannon CP, Morrow D et al (2005) Pravastatin or atorvastatin evaluation and infection therapy—thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28
NCBI OMIM database (2008) Johns Hopkins University. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=123260. Cited 2 Jan 2008
Kovacs A, Green F, Hansson LO et al (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178:193–198
Brull DJ, Serrano N, Zito F et al (2003) Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23:2063–2069
Lange LA, Carlson CS, Hindorff LA et al (2006) Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296:2703–2711
Crawford DC, Sanders CL, Qin X et al (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114:2458–2465
Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168
Pasceri V, Cheng JS, Willerson JT, Yeh ET (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534
Wang G, Siow YL, O K (2000) Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Biochem J 352 Pt 3:817–826
Hattori Y, Matsumura M, Kasai K (2003) Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 58:186–195
Wang G, Siow YL, O K (2001) Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappaB in THP-1 macrophages. Am J Physiol Heart Circ Physiol 280:H2840–H2847
Cao H, Hegele RA (2000) Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 45:100–101
Suk HJ, Ridker PM, Cook NR, Zee RY (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178:139–145
Araujo F, Pereira AC, Mota GF, Latorre Mdo R, Krieger JE, Mansur AJ (2004) The influence of tumor necrosis factor-308 and C-reactive protein G1059C gene variants on serum concentration of C-reactive protein: evidence for an age-dependent association. Clin Chim Acta 349:129–134
Zee RY, Hegener HH, Fernandez-Cruz A, Lindpaintner K (2004) C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis. Atherosclerosis 176:393–396
Suk Danik J, Chasman DI, Cannon CP et al (2006) Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet 70:705–716
Eklund C, Lehtimaki T, Hurme M (2005) Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet 32:229–232
Chen J, Zhao J, Huang J, Su S, Qiang B, Gu D (2005) -717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. J Mol Med 83:72–78
Miller DT, Zee RY, Suk Danik J et al (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69:623–638
Ridker PM (2003) High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 92(4B):17K–22K
Harrington JR (2000) The role of MCP-1 in atherosclerosis. Stem Cells 18:65–66
Hai CM (2007) Airway smooth muscle cell as therapeutic target of inflammation. Curr Med Chem 14:67–76
Girelli D, Martinelli N, Olivieri O et al (2006) Hyperhomocysteinemia and mortality after coronary artery bypass grafting. PLoS ONE 1:e83
Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni N (2006) Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 43:275–283
Li JJ, Fang CH, Chen MZ, Chen X, Lee SW (2004) Activation of nuclear factor-kappaB and correlation with elevated plasma C-reactive protein in patients with unstable angina. Heart Lung Circ 13:173–178
Acknowledgments
This investigation was supported by Project Grants No. 108247 and 108-1080316-0298 of the Croatian Ministry of Science, Education and Sport.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pašalić, D., Marinković, N., Gršković, B. et al. C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease. Mol Biol Rep 36, 775–780 (2009). https://doi.org/10.1007/s11033-008-9244-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-008-9244-1